Contact urticaria during topical immunotherapy.
Tosti
A
A
Department of Dermatology, University of Bologna, Italy.
Guerra
L
L
Bardazzi
F
F
D000287:Administration, Topical; D000328:Adult; D000506:Alopecia Areata / Q000628:therapy*; D003503:Cyclobutanes / Q000009:adverse effects*; D003521:Cyclopropanes / Q000009:adverse effects*; D003877:Dermatitis, Contact / Q000209:etiology*; D004137:Dinitrochlorobenzene / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D014581:Urticaria / Q000139:chemically induced*
D003503:Cyclobutanes; D003521:Cyclopropanes; D004137:Dinitrochlorobenzene; C020637:squaric acid dibutyl ester; C029402:diphenylcyclopropenone